New

Turn ETF ideas into real portfolios. Try the builder now →

Advertisement

PJPvsIBBETF Comparison

ETF 1
PJP

Invesco Dynamic Pharmaceuticals ETF

This fund is part of
US Health Care
+0.03%
VS
ETF 2
IBB

iShares Biotechnology ETF

This fund is part of
US Health Care
+0.03%

Invesco Dynamic Pharmaceuticals ETF (PJP) and iShares Biotechnology ETF (IBB) belong to the same industry segment: US Health Care. PJP's top 1 sector exposures are Healthcare. In contrast, IBB's top sector exposures are Healthcare, Non-Corporate and Non-Energy Materials. PJP is more expensive with a Total Expense Ratio (TER) of 0.58%, versus 0.44% for IBB. PJP is up 24.33% year-to-date (YTD) with +$176M in YTD flows. IBB performs better with 29.03% YTD performance, and +$778M in YTD flows. Run a side-by-side ETF comparison of PJP and IBB below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

PJP vs IBB performance and flow charts

Performance

-4.0-2.00.02.04.06.0%Sep 30Oct 7Oct 14Oct 21Oct 28

Cumulative Flows

0 M100 M200 M300 M400 M500 MSep 30Oct 7Oct 14Oct 21Oct 28

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 10/29/2026
1M3MYTD1Y3Y5Y
Perf.
PJP
IBB
+2.22%+3.39%
+5.70%+14.54%
+24.33%+29.03%
+37.12%+38.56%
+93.50%+93.88%
+71.45%+36.26%
Flows
PJP
IBB
-$6M+$470M
+$79M+$756M
+$176M+$778M
+$192M+$2.00B
+$135M+$134M
-$15M-$895M
Volatility and drawdown
3M1Y3Y5Y
Volatility
PJP
IBB
+17.69%+26.21%
+17.60%+22.73%
+16.44%+21.38%
+16.62%+22.58%
Max drawdown
PJP
IBB
-7.99%-7.78%
-9.42%-9.61%
-16.11%-24.82%
-17.41%-35.62%
Max drawdown duration
PJP
IBB
71d70d
108d151d
275d377d
788d1468d
Trading data

Create an account to view trading data

Join for free
PJP
IBB
Last sale
10/30/2026 at 1:30 PM
$130.54
$217.61
Previous close
10/29/2026
$128.88
$217.86
Consolidated volume
10/29/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of September 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
PJP
IBB
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Main metrics
Last update 10/30/2026 at 1:30 PM
Live
Closed
PJP
IBB
Last price
$130.54
$217.61
1D performance
+1.29%
-0.11%
AuM$575.08 M$11.50 B
E/R0.58%0.44%
Characteristics
PJP
IBB
Management strategyPassivePassive
ProviderInvescoiShares
BenchmarkDynamic Pharmaceutical Intellidex IndexNYSE Biotechnology Index
N° of holdings27235
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJune 23, 2005February 5, 2001
ESGNoNo
Advertisement
Exposure

Countries

PJP
USA
93.91%
Other
6.09%
IBB
USA
86.37%
Other
13.63%

Sectors

PJP
Healthcare
100%
Other
0%
IBB
Healthcare
99.85%
Other
0.15%
Advertisement

Diversification

PJP

Total weight of top 15 holdings out of 15

65.76%
IBB

Total weight of top 15 holdings out of 15

58.82%

Top 15 holdings

Data as of September 30, 2026
PJP
Gilead Sciences, Inc.
5.58%
Pfizer Inc.
5.49%
AbbVie, Inc.
5.47%
Johnson & Johnson
5.43%
Eli Lilly & Co.
5.24%
Merck & Co., Inc.
5.19%
Amgen, Inc.
5.15%
Abbott Laboratories
4.74%
Amneal Pharmaceuticals, Inc.
3.56%
Ligand Pharmaceuticals, Inc.
3.47%
Viatris, Inc.
3.40%
Tarsus Pharmaceuticals, Inc.
3.34%
Liquidia Corp.
3.25%
Perrigo Co. Plc
3.24%
Biogen, Inc.
3.22%
IBB
Gilead Sciences, Inc.
8.08%
Amgen, Inc.
7.78%
Vertex Pharmaceuticals, Inc.
7.62%
Regeneron Pharmaceuticals, Inc.
5.28%
Moderna, Inc.
4.94%
Natera, Inc.
3.91%
argenx SE
3.74%
Illumina, Inc.
2.89%
Revolution Medicines, Inc.
2.78%
Biogen, Inc.
2.33%
Alnylam Pharmaceuticals, Inc.
2.31%
BeOne Medicines Ltd.
2.16%
Insmed, Inc.
1.72%
Incyte Corp.
1.71%
United Therapeutics Corp.
1.58%
Frequently asked questions about PJP and IBB

How have the PJP and IBB ETFs performed in 2026?

As of October 29, 2026, PJP is up 24.33% year-to-date (YTD), while IBB has returned 29.03%. That puts IBB better performer ahead so far this year.

Which ETF is attracting more investor money: PJP or IBB?

Year-to-date, the PJP ETF saw +$176M in flows, compared to +$778M for IBB.

Which ETF is more volatile: PJP or IBB?

Over the past year, PJP had a volatility of 17.6%, while IBB experienced 22.73%.

Which ETF is bigger: PJP or IBB?

As of October 29, 2026, PJP holds $575.08 M in assets under management (AUM), while IBB manages $11.50 B.

What sectors do the PJP and IBB ETFs invest in?

PJP leans toward sectors like Healthcare. Meanwhile, IBB focuses on Healthcare.

What are the top holdings of the PJP ETF and IBB ETF?

PJP top holdings include Gilead Sciences, Inc., Pfizer Inc. and AbbVie, Inc.. IBB holds in its top three: Gilead Sciences, Inc., Amgen, Inc. and Vertex Pharmaceuticals, Inc..

Which ETF is more diversified: PJP or IBB?

PJP holds 27 securities with 65.76% of its assets in the top 15. IBB has 237 securities and a top 15 weight of 58.82%.

Advertisement
Advertisement
New Report

ETFs’ Next Act: From Access to Selection

Global ETF Survey 2026